| Gene Symbol | HLA-DQB1 |
| Entrez ID | 3119 |
| Uniprot ID | P01920 |
| Description | major histocompatibility complex, class II, DQ beta 1 |
| Chromosomal Location | chr6: 32,659,467-32,668,383 |
| Ontology | GO ID | GO Term | Definition | Evidence |
|---|---|---|---|---|
BP | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response |
The appearance of immunoglobulin due to biosynthesis or secretion following a cellular stimulus during an immune response, resulting in an increase in its intracellular or extracellular levels. | IDA |
BP | GO:0002455 | humoral immune response mediated by circulating immunoglobulin |
An immune response dependent upon secreted immunoglobulin. An example of this process is found in Mus musculus. | IDA |
BP | GO:0006955 | immune response |
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. | NAS |
BP | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II |
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein. | TAS |
BP | GO:0031295 | T cell costimulation |
The process of providing, via surface-bound receptor-ligand pairs, a second, antigen-independent, signal in addition to that provided by the T cell receptor to augment T cell activation. | TAS |
BP | GO:0050852 | T cell receptor signaling pathway |
A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell. | TAS |
BP | GO:0060333 | interferon-gamma-mediated signaling pathway |
A series of molecular signals initiated by the binding of interferon-gamma to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Interferon gamma is the only member of the type II interferon found so far. | TAS |
CC | GO:0000139 | Golgi membrane |
The lipid bilayer surrounding any of the compartments of the Golgi apparatus. | TAS |
CC | GO:0005765 | lysosomal membrane |
The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm. | TAS |
CC | GO:0005886 | plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. | TAS |
CC | GO:0010008 | endosome membrane |
The lipid bilayer surrounding an endosome. | IEA |
CC | GO:0012507 | ER to Golgi transport vesicle membrane |
The lipid bilayer surrounding a vesicle transporting substances from the endoplasmic reticulum to the Golgi. | TAS |
CC | GO:0016020 | membrane |
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. | IDA|NAS |
CC | GO:0030658 | transport vesicle membrane |
The lipid bilayer surrounding a transport vesicle. | TAS |
CC | GO:0030666 | endocytic vesicle membrane |
The lipid bilayer surrounding an endocytic vesicle. | TAS |
CC | GO:0030669 | clathrin-coated endocytic vesicle membrane |
The lipid bilayer surrounding a clathrin-coated endocytic vesicle. | TAS |
CC | GO:0032588 | trans-Golgi network membrane |
The lipid bilayer surrounding any of the compartments that make up the trans-Golgi network. | TAS |
CC | GO:0042613 | MHC class II protein complex |
A transmembrane protein complex composed of an MHC class II alpha and MHC class II beta chain, and with or without a bound peptide or polysaccharide antigen. | ISS |
CC | GO:0071556 | integral component of lumenal side of endoplasmic reticulum membrane |
The component of the endoplasmic reticulum membrane consisting of the gene products that penetrate only the lumenal side of the membrane. | TAS |
MF | GO:0032395 | MHC class II receptor activity |
Combining with an MHC class II protein complex and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. | NAS |
MF | GO:0042605 | peptide antigen binding |
Interacting selectively and non-covalently with an antigen peptide. | ISS |
| Domain ID | Description |
|---|---|
IPR000353 | MHC class II, beta chain, N-terminal |
IPR003006 | Immunoglobulin/major histocompatibility complex, conserved site |
IPR003597 | Immunoglobulin C1-set |
IPR007110 | Immunoglobulin-like domain |
IPR011162 | MHC classes I/II-like antigen recognition protein |
IPR013783 | Immunoglobulin-like fold |
IPR014745 | MHC class II, alpha/beta chain, N-terminal |
| Pathway ID | Pathway Term | Pathway Source |
|---|---|---|
hsa04145 | Phagosome | KEGG |
hsa04514 | Cell adhesion molecules (CAMs) | KEGG |
hsa04612 | Antigen processing and presentation | KEGG |
hsa04640 | Hematopoietic cell lineage | KEGG |
hsa04658 | Th1 and Th2 cell differentiation | KEGG |
hsa04659 | Th17 cell differentiation | KEGG |
hsa04672 | Intestinal immune network for IgA production | KEGG |
hsa04940 | Type I diabetes mellitus | KEGG |
hsa05140 | Leishmaniasis | KEGG |
hsa05145 | Toxoplasmosis | KEGG |
hsa05150 | Staphylococcus aureus infection | KEGG |
hsa05152 | Tuberculosis | KEGG |
hsa05164 | Influenza A | KEGG |
hsa05166 | HTLV-I infection | KEGG |
hsa05168 | Herpes simplex infection | KEGG |
hsa05169 | Epstein-Barr virus infection | KEGG |
hsa05310 | Asthma | KEGG |
hsa05320 | Autoimmune thyroid disease | KEGG |
hsa05321 | Inflammatory bowel disease (IBD) | KEGG |
hsa05322 | Systemic lupus erythematosus | KEGG |
hsa05323 | Rheumatoid arthritis | KEGG |
hsa05330 | Allograft rejection | KEGG |
hsa05332 | Graft-versus-host disease | KEGG |
hsa05416 | Viral myocarditis | KEGG |
WP2328 | Allograft Rejection | WikiPathways |
| UMLS CUI | UMLS Term |
|---|---|
C0002994 | Angioedema |
C0004096 | Asthma |
C0007570 | Celiac Disease |
C0011609 | Drug Eruptions |
C0011854 | Diabetes Mellitus, Insulin-Dependent |
C0014848 | Esophageal Achalasia |
C0017661 | Iga Glomerulonephritis |
C0020517 | Hypersensitivity |
C0022336 | Creutzfeldt-Jakob Disease |
C0026769 | Multiple Sclerosis |
C0027404 | Narcolepsy |
C0030805 | Bullous Pemphigoid |
C0036421 | Systemic Scleroderma |
C0042109 | Urticaria |
C0751362 | Narcolepsy-Cataplexy Syndrome |
C0860207 | Drug-Induced Liver Injury |
| Tissue | Cell Type |
|---|---|
appendix | lymphoid tissue |
cerebellum | Purkinje cells |
fallopian tube | glandular cells |
lung | macrophages |
lymph node | germinal center cells |
skin | Langerhans |
spleen | cells in white pulp |
thyroid gland | glandular cells |
tonsil | germinal center cells |
tonsil | non-germinal center cells |
| Pubmed ID | Author | Year | Title |
|---|---|---|---|
15308691 | Jansen et al. | 2004 | Abnormal Gene Expression Profiles in Human Ovaries from Polycystic Ovary Syndrome Patients |
17062763 | Corton et al. | 2007 | Differential Gene Expression Profile in Omental Adipose Tissue in Women with Polycystic Ovary Syndrome |
22617121 | Ouandaogo et al. | 2012 | Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
22904171 | Kaur et al. | 2012 | Differential Gene Expression in Granulosa Cells from Polycystic Ovary Syndrome Patients with and without Insulin Resistance: Identification of Susceptibility Gene Sets through Network Analysis |
| Gene Symbol | Entrez ID | Uniprot ID | Score |
|---|---|---|---|
HLA-DQA1 | 3117 | P01909 | 0.82 |